1. Home
  2. RCEL vs EVG Comparison

RCEL vs EVG Comparison

Compare RCEL & EVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • EVG
  • Stock Information
  • Founded
  • RCEL N/A
  • EVG 2005
  • Country
  • RCEL United States
  • EVG United States
  • Employees
  • RCEL N/A
  • EVG N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • EVG Investment Managers
  • Sector
  • RCEL Health Care
  • EVG Finance
  • Exchange
  • RCEL Nasdaq
  • EVG Nasdaq
  • Market Cap
  • RCEL 161.5M
  • EVG 146.4M
  • IPO Year
  • RCEL N/A
  • EVG N/A
  • Fundamental
  • Price
  • RCEL $5.19
  • EVG $10.80
  • Analyst Decision
  • RCEL Strong Buy
  • EVG
  • Analyst Count
  • RCEL 4
  • EVG 0
  • Target Price
  • RCEL $16.50
  • EVG N/A
  • AVG Volume (30 Days)
  • RCEL 287.8K
  • EVG 49.4K
  • Earning Date
  • RCEL 08-07-2025
  • EVG 01-01-0001
  • Dividend Yield
  • RCEL N/A
  • EVG 8.68%
  • EPS Growth
  • RCEL N/A
  • EVG N/A
  • EPS
  • RCEL N/A
  • EVG N/A
  • Revenue
  • RCEL $71,661,000.00
  • EVG N/A
  • Revenue This Year
  • RCEL $57.29
  • EVG N/A
  • Revenue Next Year
  • RCEL $28.07
  • EVG N/A
  • P/E Ratio
  • RCEL N/A
  • EVG N/A
  • Revenue Growth
  • RCEL 41.35
  • EVG N/A
  • 52 Week Low
  • RCEL $5.10
  • EVG $9.13
  • 52 Week High
  • RCEL $14.16
  • EVG $10.86
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 29.07
  • EVG 47.01
  • Support Level
  • RCEL $5.10
  • EVG $10.80
  • Resistance Level
  • RCEL $6.33
  • EVG $11.11
  • Average True Range (ATR)
  • RCEL 0.32
  • EVG 0.10
  • MACD
  • RCEL 0.02
  • EVG -0.00
  • Stochastic Oscillator
  • RCEL 6.10
  • EVG 22.50

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About EVG Eaton Vance Short Diversified Income Fund Eaton Vance Short Duration Diversified Income Fund of Beneficial Interest

Eaton Vance Short Duration Diversified Income Fund is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income with a secondary objective of seeking capital appreciation to the extent consistent with its primary goal. The portfolio of investments consists of business equipment and services, automotive, cable and satellite television, chemicals and plastics, food products, and other areas.

Share on Social Networks: